Tuberculosis, Gut Microbiota, Metabonomic/Metabolomics, Indole-3-Propionic acid (IPA), Aryl hydrocarbon receptor (AhR)
Tuberculosis, gut microbiota, Metabolomics, Indole-3-Propionic acid
Hepatocellular carcinoma, Microvascular invasion, Non-invasive predictive models, machine learning, Extreme gradient boosting (XGBoost)
Immune checkpoint inhibitors, Immune-related adverse events, Circulating transcriptome, FXYD7